Recalls / Firms / Exela Pharma Sciences LLC
Exela Pharma Sciences LLC
12 FDA drug recalls on record — 7 Class I.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2025-07-30 | Class II | Sodium Bicarbonate | Ongoing |
| 2025-03-07 | Class II | Sodium Bicarbonate | Ongoing |
| 2023-10-18 | Class I | Elcys | Ongoing |
| 2023-10-18 | Class I | Sodium Bicarbonate | Ongoing |
| 2023-10-18 | Class I | Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL (1mg/mL), 100 mL Single-Dose Via | Ongoing |
| 2022-11-28 | Class I | 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, pa | Terminated |
| 2022-11-28 | Class I | Sodium Bicarbonate | Terminated |
| 2022-10-04 | Class I | Sodium Bicarbonate | Terminated |
| 2022-10-04 | Class I | 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, pa | Terminated |
| 2022-01-11 | Class II | 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, Rx Only, Manu | Terminated |
| 2020-05-05 | Class III | Potassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) Single Dose Vials, Rx only, Manu | Terminated |
| 2018-04-20 | Class II | Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-count bottle, R | Terminated |